Destiny Pharma Says New Guidelines Prove Lead Product Marketability
Destiny Pharma Says New Guidelines Prove Lead Product Marketability
Read moreDestiny Pharma Says New Guidelines Prove Lead Product Marketability
Read moreDestiny Pharma Appoints Former Polyphor Medical Chief To Board
Read more(Sharecast News) - Clinical stage biotechnology company Destiny Pharma reported on the publication of results from a positive phase 1 clinical study in 60 healthy United States volunteers using a nasal gel formulation of its lead drug, XF-73 (exeporfinium chloride), on Wednesday.
Read moreDestiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus
Read moreDestiny Pharma Says Non-Executive Joe Eagle Steps Down From Board
Read moreDestiny Pharma Interim Loss Narrows On Smaller Share Option Charge
Read more(Alliance News) - Destiny Pharma PLC on Tuesday said it has been awarded a grant along with the University of Sheffield for their research collaboration on drug-resistant infections.Shares
Read moreLONDON (Alliance News) - Destiny Pharma PLC on Tuesday reported a significantly widened annual loss as expenses surged in the run-up to the development of its lead candidate.For 2018, the a
Read more(Sharecast News) - Destiny Pharma on Tuesday reported a wider annual loss as it increased research and development costs, although the company is "well funded" through to the second half of next year.
Read moreWednesday 3 April AAFull Year ResultsCMC MarketsTrading GroupTrading Year Year 4
Read moreLONDON (Alliance News) - Destiny Pharma PLC on Wednesday said it has partnered with MedPharm to develop new formulations of its XF-platform compounds.MedPharm is a contract provider of and
Read moreLONDON (Alliance News) - Destiny Pharma PLC on Monday reported positive results in a second phase 1 clinical study examining the anti-irritation features of its XF-73 nasal gel.The study, a
Read more(Sharecast News) - Clinical stage biotechnology company Destiny Pharma announced positive data and the non-irritant classification for its XF-73 nasal gel on Monday.
Read more(Sharecast News) - Destiny Pharma jumped on Friday after being awarded funding of up to £1.6m from a collaboration established under the UK-China AMR grant fund.
Read moreLONDON (Alliance News) - Destiny Pharma PLC said Friday that it has secured a GBP1.6 million grant for examining novel drugs to prevent, control and eradicate life threatening bacteria or without
Read more